
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity
Eric L. Dane, Alexis Belessiotis‐Richards, Coralie M. Backlund, et al.
Nature Materials (2022) Vol. 21, Iss. 6, pp. 710-720
Open Access | Times Cited: 206
Eric L. Dane, Alexis Belessiotis‐Richards, Coralie M. Backlund, et al.
Nature Materials (2022) Vol. 21, Iss. 6, pp. 710-720
Open Access | Times Cited: 206
Showing 1-25 of 206 citing articles:
The cGAS–STING pathway and cancer
Natasha Samson, Andrea Ablasser
Nature Cancer (2022) Vol. 3, Iss. 12, pp. 1452-1463
Closed Access | Times Cited: 283
Natasha Samson, Andrea Ablasser
Nature Cancer (2022) Vol. 3, Iss. 12, pp. 1452-1463
Closed Access | Times Cited: 283
Targeted modulation of immune cells and tissues using engineered biomaterials
Parisa Yousefpour, Kaiyuan Ni, Darrell J. Irvine
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 2, pp. 107-124
Open Access | Times Cited: 82
Parisa Yousefpour, Kaiyuan Ni, Darrell J. Irvine
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 2, pp. 107-124
Open Access | Times Cited: 82
Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles
Pere Dosta, Alexander M. Cryer, Michelle Z. Dion, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 11, pp. 1351-1363
Closed Access | Times Cited: 75
Pere Dosta, Alexander M. Cryer, Michelle Z. Dion, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 11, pp. 1351-1363
Closed Access | Times Cited: 75
Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity
Xiaona Chen, Fanchao Meng, Yiting Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 74
Xiaona Chen, Fanchao Meng, Yiting Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 74
Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy
Jun‐Long Liang, Xiao‐Kang Jin, Shi‐Man Zhang, et al.
Science Bulletin (2023) Vol. 68, Iss. 6, pp. 622-636
Closed Access | Times Cited: 65
Jun‐Long Liang, Xiao‐Kang Jin, Shi‐Man Zhang, et al.
Science Bulletin (2023) Vol. 68, Iss. 6, pp. 622-636
Closed Access | Times Cited: 65
Boosting Checkpoint Immunotherapy with Biomaterials
Lujie Liu, Yuanwei Pan, Chenchen Zhao, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 3225-3258
Closed Access | Times Cited: 57
Lujie Liu, Yuanwei Pan, Chenchen Zhao, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 3225-3258
Closed Access | Times Cited: 57
Materials engineering strategies for cancer vaccine adjuvant development
Xuanbo Zhang, Bowei Yang, Qianqian Ni, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 9, pp. 2886-2910
Open Access | Times Cited: 55
Xuanbo Zhang, Bowei Yang, Qianqian Ni, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 9, pp. 2886-2910
Open Access | Times Cited: 55
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy
Lihong Wang-Bishop, Blaise R. Kimmel, Verra M. Ngwa, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 49
Lihong Wang-Bishop, Blaise R. Kimmel, Verra M. Ngwa, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 49
Polymeric STING Pro‐agonists for Tumor‐Specific Sonodynamic Immunotherapy
Jie Yu, Shasha He, Chi Zhang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 32
Closed Access | Times Cited: 44
Jie Yu, Shasha He, Chi Zhang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 32
Closed Access | Times Cited: 44
Bioactivable STING Nanoagonists to Synergize NIR‐II Mild Photothermal Therapy Primed Robust and Long‐Term Anticancer Immunity
Wen Ma, Rui Sun, Longguang Tang, et al.
Advanced Materials (2023) Vol. 35, Iss. 48
Closed Access | Times Cited: 44
Wen Ma, Rui Sun, Longguang Tang, et al.
Advanced Materials (2023) Vol. 35, Iss. 48
Closed Access | Times Cited: 44
Emerging biomaterials for tumor immunotherapy
Minna Xiao, Qinglai Tang, Shiying Zeng, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 42
Minna Xiao, Qinglai Tang, Shiying Zeng, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 42
Simultaneous Activation of Pyroptosis and cGAS‐STING Pathway with Epigenetic/ Photodynamic Nanotheranostic for Enhanced Tumor Photoimmunotherapy
Feixiang Ding, Junyan Liu, Kelong Ai, et al.
Advanced Materials (2023) Vol. 36, Iss. 7
Open Access | Times Cited: 41
Feixiang Ding, Junyan Liu, Kelong Ai, et al.
Advanced Materials (2023) Vol. 36, Iss. 7
Open Access | Times Cited: 41
pH-gated nanoparticles selectively regulate lysosomal function of tumour-associated macrophages for cancer immunotherapy
Mingmei Tang, Binlong Chen, Heming Xia, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40
Mingmei Tang, Binlong Chen, Heming Xia, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Cuproptotic nanoinducer-driven proteotoxic stress potentiates cancer immunotherapy by activating the mtDNA–cGAS–STING signaling
Xinying Yu, Bei Li, Jie Yan, et al.
Biomaterials (2024) Vol. 307, pp. 122512-122512
Closed Access | Times Cited: 29
Xinying Yu, Bei Li, Jie Yan, et al.
Biomaterials (2024) Vol. 307, pp. 122512-122512
Closed Access | Times Cited: 29
An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy
Yuhua Cao, Shuaishuai Ding, Yunping Hu, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4189-4204
Closed Access | Times Cited: 27
Yuhua Cao, Shuaishuai Ding, Yunping Hu, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4189-4204
Closed Access | Times Cited: 27
STING licensing of type I dendritic cells potentiates antitumor immunity
Jian Wang, Suxin Li, M. C. Wang, et al.
Science Immunology (2024) Vol. 9, Iss. 92
Open Access | Times Cited: 27
Jian Wang, Suxin Li, M. C. Wang, et al.
Science Immunology (2024) Vol. 9, Iss. 92
Open Access | Times Cited: 27
Enhancing in situ cancer vaccines using delivery technologies
Ningqiang Gong, Mohamad‐Gabriel Alameh, Rakan El‐Mayta, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 607-625
Closed Access | Times Cited: 22
Ningqiang Gong, Mohamad‐Gabriel Alameh, Rakan El‐Mayta, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 607-625
Closed Access | Times Cited: 22
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 21
A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy
Na Li, Shinan Geng, Zhenzhen Dong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
Na Li, Shinan Geng, Zhenzhen Dong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview
Xu Liu, Cheng Yang, Yao Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Xu Liu, Cheng Yang, Yao Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
cGAS‐STING pathway agonists are promising vaccine adjuvants
Xinyu Tian, Jiayuan Ai, Xiaohe Tian, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1768-1799
Open Access | Times Cited: 15
Xinyu Tian, Jiayuan Ai, Xiaohe Tian, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1768-1799
Open Access | Times Cited: 15
Ionizable STING-Activating Nanoadjuvants Enhance Tumor Immunogenicity and Potentiate Immunotherapy Efficacy in Solid Tumors
Shiyun Xian, Xiaona Chen, Sihang Ren, et al.
Cancer Research (2024) Vol. 84, Iss. 18, pp. 3044-3057
Closed Access | Times Cited: 15
Shiyun Xian, Xiaona Chen, Sihang Ren, et al.
Cancer Research (2024) Vol. 84, Iss. 18, pp. 3044-3057
Closed Access | Times Cited: 15
Pyridinium Rotor Strategy toward a Robust Photothermal Agent for STING Activation and Multimodal Image-Guided Immunotherapy for Triple-Negative Breast Cancer
Shipeng Ning, Ping Shangguan, Xinyan Zhu, et al.
Journal of the American Chemical Society (2025) Vol. 147, Iss. 9, pp. 7433-7444
Open Access | Times Cited: 1
Shipeng Ning, Ping Shangguan, Xinyan Zhu, et al.
Journal of the American Chemical Society (2025) Vol. 147, Iss. 9, pp. 7433-7444
Open Access | Times Cited: 1
Nanodelivery of cGAS-STING activators for tumor immunotherapy
Jianfeng Guo, Leaf Huang
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 11, pp. 957-972
Open Access | Times Cited: 54
Jianfeng Guo, Leaf Huang
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 11, pp. 957-972
Open Access | Times Cited: 54